Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Decitabine + tetrahydrouridine) by Epidestiny for Melanoma: Likelihood of Approval
(Decitabine + tetrahydrouridine) is under clinical development by Epidestiny and currently in Phase I for Melanoma. According to GlobalData, Phase...